Wall Street Zen has upgraded Devon Energy (NYSE:DVN) from a "hold" to a "buy" rating, contributing to a "Moderate Buy" consensus among analysts with an average price target of $58.67. This comes amidst other firms like Mizuho, Wolfe Research, and Raymond James also raising their price targets, and Raymond James issuing a "strong-buy" rating. Despite recent insider selling and mixed quarterly results where EPS and revenue missed forecasts, institutional investors have shown increased interest, with significant stake increases from several hedge funds.

Stryker reported that a cyber incident in early 2026 disrupted operations but did not significantly impact demand, attributing continued growth to record Mako robotics installations, expanded use cases, and strong international market contributions. Despite a year-to-date stock decline of 10.3% and a 16.5% drop over the past year, the company has seen a 29.0% increase over five years, trading around $312.2. The article highlights investor interest in Stryker's ability to reinforce systems post-cyber event and expand its Mako platform and international approvals, noting the stock trades below analyst targets and its estimated fair value.

NiSource offers a Home Energy Management program to eligible US households, providing smart thermostat rebates, optimization, and personalized insights to reduce energy use and monthly bills. The service integrates smart thermostats, data analytics, and targeted rebates to help residential customers cut electricity and natural gas consumption while maintaining home comfort. It's offered through NiSource operating companies like Columbia Gas and NIPSCO, focusing on smart thermostat enrollment, time-of-use awareness, and customized efficiency recommendations.

E. Kevin Hrusovsky, a director at 908 Devices (NASDAQ: MASS), was granted 6,209 stock options at an exercise price of $8.22 and 13,656 Restricted Stock Units (RSUs) on June 11, 2026. Additionally, 14,083 RSUs vested and converted into common stock on June 10, 2026, increasing his direct holdings to 165,390 shares, with an additional 329,675 shares held indirectly through a trust. These transactions are part of his compensation and are detailed in a Form 4 SEC filing.

CenterPoint Energy (CNP) is highlighted as an energy stock benefiting from the data center boom, with strong analyst ratings and a positive outlook for its industrial load pipeline, particularly in the Greater Houston area. Despite some analyst price target reductions, the company reported increased net income in Q1, and expects to energize 8 gigawatts of projects by 2029. The article also suggests that while CNP has potential, certain AI stocks might offer greater upside and less downside risk.

This article provides financial information for NextEra Energy, Inc. 7.234% Corporate (NYSE: NEE/PT), specifically focusing on its free cash flow per share. It appears to be a financial data page from TradingView, displaying the stock's performance and offering various financial tools and data. The content primarily lists navigation links and copyright information for financial data providers.

This article provides the title and stock ticker for Hawthorn Bancshares, Inc. (NASDAQ: HWBK), focusing on the metric "Loan losses (actual) to total loans." It indicates that the market was closed at the time of the information provided and directs users to TradingView for more financial and market data on the company.

Coherent has solidified its partnership with NVIDIA through a $2 billion investment focused on AI datacenter optical and photonics technologies. Concurrently, Coherent is addressing Chinese export controls on indium phosphide by increasing internal production and diversifying manufacturing locations. These strategic moves aim to reinforce Coherent's position in the AI optics market while mitigating supply chain risks.

This article provides financial data for KeyCorp (BX:KEYUSD), specifically focusing on its net revenue after provisions. It includes information on period values and changes, noting that the market is currently closed with no trades. The content is primarily a data placeholder from TradingView, indicating financial metrics for the company.

Boston Scientific (BSX) shares have fallen over 50% year-to-date due to management repeatedly lowering its 2026 organic revenue growth guidance. Despite this significant drop and market pessimism, 27 out of 31 analysts still rate the stock as a "buy" with a consensus price target suggesting a 65% upside. The company's valuation is comparable to peers, and a premium valuation will depend on a faster-than-expected recovery in growth.